Microbiome Modulation in Liver Disease
Eamonn M.M. Quigley – 6 November 2019
Liver‐Intestine/Multivisceral Perspective: Indications, Patient Selection, and Allocation Policy
Richard S. Mangus – 6 November 2019
AGA Clinical Practice Update on Surgical Risk Assessment and Perioperative Management in Cirrhosis: Expert Review
Patrick G. Northup, Lawrence S. Friedman, Patrick S. Kamath – 6 November 2019
The Development and Outcome of Acute‐on‐Chronic Liver Failure After Surgical Interventions
Leah Maria Klein, Johannes Chang, Wenyi Gu, Steffen Manekeller, Christian Jansen, Philipp Lingohr, Michael Praktiknjo, Jörg C. Kalf, Martin Schulz, Ulrich Spengler, Christian Strassburg, Andrés Cárdenas, Vicente Arroyo, Jonel Trebicka – 6 November 2019 – Acute‐on‐chronic liver failure (ACLF) is a syndrome with high short‐term mortality. Precipitating events, including hemorrhage and infections, contribute to ACLF development, but the role of surgery remains unknown. We investigated the development of ACLF in patients with cirrhosis undergoing surgery.
Relationship of Physician Counseling to Weight Loss Among Patients With Nonalcoholic Fatty Liver Disease: An Observational Cohort Study Using National Health and Education Survey Data
Jessica P.E. Davis, Zachary H. Henry, Curtis K. Argo, Patrick G. Northup – 6 November 2019
When Theory Becomes Reality: Navigating the Ethics of Transplanting Hepatitis C Virus–Positive Livers Into Negative Recipients
Thomas Couri, Andrew Aronsohn – 6 November 2019
When Theory Becomes Reality: Navigating the Ethics of Transplanting Hepatitis C Virus–Positive Livers Into Negative Recipients
Thomas Couri, Andrew Aronsohn – 6 November 2019
Circulating MicroRNA‐122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLD
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada – 5 November 2019 – The impact of circulating microRNA‐122 (miR‐122) on mortality in patients with histopathologically confirmed nonalcoholic fatty liver disease (NAFLD) remains unclear. We analyzed the overall survival rates in 441 Japanese patients with histopathologically confirmed NAFLD after a median follow‐up period of 4.7 years.
Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery
Alina M. Allen, Vijay H. Shah, Terry M. Therneau, Sudhakar K. Venkatesh, Taofic Mounajjed, Joseph J. Larson, Kristin C. Mara, Todd A. Kellogg, Michael L. Kendrick, Travis J. McKenzie, Suzanne M. Greiner, Jiahui Li, Kevin J. Glaser, Michael L. Wells, Timothy J. Gunneson, Richard L. Ehman, Meng Yin – 5 November 2019 – Disease monitoring in nonalcoholic steatohepatitis (NASH) is limited by absence of noninvasive biomarkers of disease regression or progression.
Something Wicked this Way Comes
Timucin Taner, Julie K. Heimbach – 4 November 2019